Sunrise Financial Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$384 Sell
9
-18
-67% -$977 ﹤0.01% 555
2026
Q1
$1.69K Buy
27
+18
+200% +$1.44K ﹤0.01% 426
2025
Q4
$858 Buy
+9
New +$882 ﹤0.01% 477

Other funds holding BSX

Sunrise Financial Services's BSX Position: Q2 2026 in Review

Sunrise Financial Services reduced its Boston Scientific (BSX) stake by 67% in Q2 2026, selling an estimated $977 and leaving 9 shares worth $384. The position accounts for ﹤0.01% of the portfolio, ranked #555.

Sunrise Financial Services first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.69K in Q1 2026. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Sunrise Financial Services held 9 shares of Boston Scientific worth $384 as of Q2 2026.
  • Sunrise Financial Services sold 18 Boston Scientific shares in Q2 2026, an estimated $977.
  • Boston Scientific made up ﹤0.01% of Sunrise Financial Services's portfolio in Q2 2026, its #555 holding.
  • Sunrise Financial Services first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Sunrise Financial Services's Boston Scientific position peaked at $1.69K in Q1 2026.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sunrise Financial Services's 13F filing for Q2 2026, filed 12 Aug 2026.